Literature DB >> 18202291

Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.

Dengli Hong1, Rajeev Gupta, Philip Ancliff, Ann Atzberger, John Brown, Shamit Soneji, Joanne Green, Sue Colman, Wanda Piacibello, Veronica Buckle, Shinobu Tsuzuki, Mel Greaves, Tariq Enver.   

Abstract

Understanding cancer pathogenesis requires knowledge of not only the specific contributory genetic mutations but also the cellular framework in which they arise and function. Here we explore the clonal evolution of a form of childhood precursor-B cell acute lymphoblastic leukemia that is characterized by a chromosomal translocation generating a TEL-AML1 fusion gene. We identify a cell compartment in leukemic children that can propagate leukemia when transplanted in mice. By studying a monochorionic twin pair, one preleukemic and one with frank leukemia, we establish the lineal relationship between these "cancer-propagating" cells and the preleukemic cell in which the TEL-AML1 fusion first arises or has functional impact. Analysis of TEL-AML1-transduced cord blood cells suggests that TEL-AML1 functions as a first-hit mutation by endowing this preleukemic cell with altered self-renewal and survival properties.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202291     DOI: 10.1126/science.1150648

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  146 in total

Review 1.  The difficulty of targeting cancer stem cell niches.

Authors:  Mark A LaBarge
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

Review 2.  The cancer stem cell paradigm: a new understanding of tumor development and treatment.

Authors:  Johnathan D Ebben; Daniel M Treisman; Michael Zorniak; Raman G Kutty; Paul A Clark; John S Kuo
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

Review 3.  Somatic mosaicism: on the road to cancer.

Authors:  Luis C Fernández; Miguel Torres; Francisco X Real
Journal:  Nat Rev Cancer       Date:  2015-12-18       Impact factor: 60.716

4.  Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy.

Authors:  Bingxue Shang; Gaochuan Zhang; Yanyan Pan; Quansheng Zhou
Journal:  Cancer Microenviron       Date:  2012-05-17

5.  Modulation of potassium channel function confers a hyperproliferative invasive phenotype on embryonic stem cells.

Authors:  Junji Morokuma; Douglas Blackiston; Dany S Adams; Guiscard Seebohm; Barry Trimmer; Michael Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-17       Impact factor: 11.205

6.  Cluster of differentiation 96 as a leukemia stem cell-specific marker and a factor for prognosis evaluation in leukemia.

Authors:  Wen DU; Yanjie Hu; Cong Lu; Juan Li; Wei Liu; Yanli He; Ping Wang; Chen Cheng; Y U Hu; Shiang Huang; Junxia Yao; Jin'e Zheng
Journal:  Mol Clin Oncol       Date:  2015-04-24

7.  Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity.

Authors:  Albert G Tsai; Haihui Lu; Sathees C Raghavan; Markus Muschen; Chih-Lin Hsieh; Michael R Lieber
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

Review 8.  How animal models of leukaemias have already benefited patients.

Authors:  Julien Ablain; Rihab Nasr; Jun Zhu; Ali Bazarbachi; Valérie Lallemand-Breittenbach; Hugues de Thé
Journal:  Mol Oncol       Date:  2013-02-11       Impact factor: 6.603

9.  Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhood acute lymphoblastic leukemia.

Authors:  Kerrie Wilson; Marian Case; Lynne Minto; Simon Bailey; Nick Bown; Jenny Jesson; Sarah Lawson; Josef Vormoor; Julie Irving
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

10.  Expression of CD133 in acute leukemia.

Authors:  Fetnat M Tolba; Mona E Foda; Howyda M Kamal; Deena A Elshabrawy
Journal:  Med Oncol       Date:  2013-03-27       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.